The predictive value of plasma biomarkers in discharged heart failure patients: Role of plasma NT-proBNP

Minerva Cardioangiologica

Volumn 64, Issue 2, 2016, Pages 157-164

  Leto, Laura ^a   Testa, Marzia ^b   Feola, Mauro ^a  

^a Department of Neurology ASL1   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Heart failure; Mortality; Patient readmission; Pro brain natriuretic peptide; Prognosis

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ACUTE HEART FAILURE; ADVERSE OUTCOME; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL READMISSION; HUMAN; MORBIDITY; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PREDICTIVE VALUE; PROGNOSIS; REVIEW; ACUTE DISEASE; BLOOD; HEART FAILURE; HOSPITAL DISCHARGE; HOSPITALIZATION; PATHOPHYSIOLOGY; TIME FACTOR;

ACUTE DISEASE; BIOMARKERS; HEART FAILURE; HOSPITALIZATION; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PATIENT DISCHARGE; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TIME FACTORS;

EID: 84992221624     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;62:e147-239.
2. Mueller C, Scholer A, Laule-Kilian K, Martina B, Schin-dler C, Buser P, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnoea. N Engl J Med 2004;350:647-54.
3. Mueller C, Breidthardt T, Laule-Kilian K, Christ M, Per-ruchoud AP. The integration of BNP and NT-proBNP into clinical medicine. Swiss Med Wkly 2007;137:4-12.
4. Chen AA, Wood MJ, Krauser DG, Baggish AL, Tung R, Anwaruddin S, et al. NT-proBNP levels, echocardiography findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy. Eur Heart J 2006;27:839-45.
5. Corell P, Gustafsson F, Kistorp C, Madsen LH, Schou M, Hildebrandt P. Effect of atrial fibrillation on plasma NT-proBNP in chronic heart failure. Int J Cardiol 2007;117:395-402.
6. Morello A, Lloyd-Jones DM, Chae CU, van Kimmenade RR, Chen AC, Baggish AL, et al. Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. Am Heart J 2007;153:90-7.
7. Bettencourt P, Azevedo A, Pimenta J, Frioes F, Ferreira S, Ferreira A. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 2004;110:2168-74.
8. Januzzi JL Jr, Sakhuja R, O'Donoghue M, Baggish AL, Anwaruddin S, Chae CU, et al. Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department. Arch Intern Med 2006;166:315-20.
9. Januzzi JL, van Kimmenade R, Lainchbury J, Bayes-Genis A, Ordonez-Llanos J, Santalo-Bel M, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: The International Collaborative of NT-proBNP Study. Eur Heart J 2006;27:330-7.
10. Gegenhuber A, Mueller T, Dieplinger B, Poelz W, Pacher R, Haltmayer M. B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failure. Clin Chim Acta 2006;370:174-9.
11. Hartmann F, Packer M, Coats AJ, Fowler MB, Krum H, Mohacsi P, et al. Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: A substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Circulation 2004;110:1780-6.
12. Santaguida PL, Don-Wauchope AC, Oremus M, McK-elvie R, Ali U, Hill SA, et al. BNP and NT-proBNP as prognostic markers in persons with acute decompen-sated heart failure: A systematic review. Heart Fail Rev 2014;19:453-70.
13. Peacock WF, Nowak R, Christenson R, DiSomma S, Neath SX, Hartmann O, et al. Short-term mortality risk in emergency department acute heart failure. Acad Emerg Med 2011;18:947-58.
14. Baggish AL, van Kimmenade R, Bayes-Genis A, Davis M, Lainchbury JG, Frampton C, et al. Hemoglobin and N-terminal pro-brain natriuretic peptide: independent and synergistic predictors of mortality in patients with acute heart failure results from the International Collaborative of NT-proBNP (ICON) study. Clin Chim Acta 2007;381:145-50.
15. van Kimmenade RR, Januzzi JL, Baggish AL, Sharma UC, Bakker JA, Low AF, et al. Amino-terminal probrain natriuretic peptide, renal function and outcomes in acute heart failure: redefining the cardiorenal interaction? J Am Coll Card 2006;48:1217-24.
16. Lourenco P, Azevedo A, Araujio JP, Bettencourt P. Natriuretic peptide system is not exhausted in severe heart failure. J Cardiovasc Med 2009;10:39-43.
17. Manzano-Fernandez S, Boronat-Garcia M, Albalade-jo-Oton MD, Pastor P, Garrido IP, Pastor-Perez FJ, et al. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic peptide and cardiac tro-ponin T in patients with acute heart failure. Am J Cardiol 2009;103:1753-9.
18. Sakhuja R, Green S, Oestreicher EM, Sluss PM, Lee-Lewandrowski E, Lewandrowski KB, et al. Amino-ter-minal pro-brain natriuretic peptide, brain natriuretic pep-tide and troponin T for prediction of mortality in acute heart failure. Clin Chem 2007;53:412-20.
19. Mohammed AA, van Kimmenade RR, Richards M, Bayes-Genis A, Pinto Y, Moore SA, et al. Hyponatremia, natriuetic peptides and oucomes in acutely decompensat-ed heart failure: results from the International Collaborative of NT-proBNP Study. Circ Heart Fail 2010;3:354-61.
20. Baggish AL, van Kimmenade RR, Pinto Y, Richards AM, Lainchbury J, Bayes-Genis A, et al. New York Heart Association class versus amino-terminal pro-B-type natriu-retic peptide for acute heart failure prognosis. Biomar-kers 2010;15:307-14.
21. Carrasco-Sanchez FJ, Galisteo-Almeda L, Paez-Rubio I, Martinez-Marcos FJ, Camacho-Vazquez C, Ruiz-Frutos C, et al. Prognostic value of cystatin C on admission in heart failure with preserved ejection fraction. J Card Fail 2011;17:31-8.
22. Pascual-Figal DA, Manzano-Fernandez S, Boronat M, Casas T, Garrido IP, Bonaque JC, et al. Soluble ST2, high-sensitivity troponin-T and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure. Eur J Heart Fail 2011;13:718-25.
23. Petretta M, Scopacasa F; Fontanella L, Carlomagno A, Baldissara M, de Simone A, et al. Prognostic value of reduced kidney function and anemia in patients with chronic heart failure. J Cardiovasc Med 2007;8:909-16.
24. Marcucci R, Gori AM, Giannotti F, Baldi M, Verdiani V, Del Pace S, et al. Markers of hypercoagulability and inflammation predict mortality in patients with heart failure. J Thromb Haemostasis 2006;4:1017-22.
25. Davutoglu V, Yildrim C, Kucukaslan H, Yuce M, Sari I, Tarakcioglu M, et al. Prognostic value of pleural effusion, CA-125 and NT-proBNP in patients with acute decompensated heart failure. Kardiol Pol 2010;68:771-8.
26. O'Brien RJ, Squire IB, Demme B, Davies JE, Ng LL. Pre-discharge, but not admission, levels of NT-proB-NP predict adverse prognosis following acute LVF. Eur J Heart Fail 2003;5:499-506.
27. Noveanu M, Breidthardt T, Potocki M, Reichlin T, Twer-enbold R, Uthoff H, et al. Direct comparison of serial B-type natriuretic peptide and NT-proBNP levels for prediction of short-and long-term outcome in acute decompensated heart failure. Crit Care 2011;15:R1.
28. Paul B, Soon KH, Dunne J, De Pasquale CG. Diagnostic and prognostic significance of plasma N-terminal-pro-brain natriuretic peptide in decompensated heart failure with preserved ejection fraction. Heart Lung Circ 2008;17:497-501.
29. Metra M, Nodari S, Parrinello G, Specchia C, Brentana L, Rocca P, et al. The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponi-T. Eur J Heart Fail 2007;9:776-86.
30. Kubler P, Jankowska EA, Majda J, Reczuch K, Bana-siak W, Ponikowski P. Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome. Int J Cardiol 2008;129:373-8.
31. Boisot S, Beede J, Isakson S, Chiu A, Clopton P, Januzzi J, et al. Serial sampling of ST2 predicts 90-day mortality followind destabilized heart failure. J Card Failure 2008;14:732-8.
32. Bayes-Genis A, Lopez L, Zapico E, Cotes C, Santalo M, Ordonez-Llanos J, et al. NT-ProBNP reduction percentage during admission for acutely decompensated heart failure predicts long-term cardiovascular mortality. J Card Fail 2005;11(5 Suppl):S3-8.
33. Verdiani V, Ognibene A, Rutili MS, Lombardo C, Bacci F, Terreni A, et al. NT-ProBNP reduction percentage during hospital stay predicts long-term mortality and readmission in heart failure patients. J Cardiovasc Med 2008;9:694-9.
34. Ferreira S, Almeida R, Guerrero H, Lourenco-Ferreira S, Fonseca L, Rocha R, et al. Prognosis of decompen-sated heart failure: role of NT-proBNP. Rev Port Cardiol 2007;28:535-45.
35. Michtalik HJ, Yeh HC, Campbell CY, Haq N, Park H, Clarke W, et al. acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of re-admission and mortality in patients with heart failure. Am J Cardiol 2011;107:1191-5.
36. Eurlings LW; Sanders-vanWijk S, van Kraaij DJW, van Kimmenade R, Meeder JG, Kamp O, et al. Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study. J Cardiac Fail 2014;20:881-90.
37. Carrasco-Sanchez FJ, Perez-Calvo JI, Morales-Rull JL, Galisteo-Almeda L, Paez-Rubio I, Baron-Franco B, et al. Heart failure mortality according to acute variations in N-terminal pro B-type natriuretic peptide and cystatin C levels. J Cardiovasc Med (Hagerstown) 2014;15:115-21.
38. Greene SJ; Maggioni AP, Fonarow GC, Solomon SD, Bohm M, Kandra A, et al. Clinical profile and prognostic significance of natriuretic peptide trajectory following hospitalization for worsening chronic heart failure: findings from the ASTRONAUT trial. Eur J Heart Fail 2015;17:98-108.